Featured news

Nanologica Delivers Silica to Latin-American Customer for Production of Insulin

As a result of Nanologica’s product in preparative chromatography, NLAB Saga®, reaching internal quality requirements, silica is now delivered to a customer in Latin America for production of diabetes drugs. The customer is a latin-american pharmaceutical manufacturer that manufactures, among other things, insulin and insulin analogues. This delivery refers to silica for the production of insulin. The delivery is made against a recent order with an order value of about TSEK 300. ”We have for

Read more »

Redeye Growth Day June 1st

Nanologica will participate at Redeye Growth Day 2023 on June 1st. CEO Andreas Bhagwani will present at 11.35. The In Focus interview is live broadcasted at https://www.redeye.se/events/871323/redeye-growth-day

Read more »

Nanologica AB (publ) has decided to focus on Chromatography and the management team is adapted to reflect the new business focus.

In order to create the best conditions for success in preparative chromatography, the company’s operations are focused on Chromatography and the Drug Development operations are down-prioritized and placed in subsidiaries for future opportunities. The management team is adapted to reflect this and CSO Gary Pitcairn and VP Drug Development Ulf Ericsson will leave the company for new opportunities. “ Our work within Drug Development has reached a point where continued development is very resource-intensive and we

Read more »

NANOLOGICA’S PRODUCT WITHIN PREPARATIVE CHROMATOGRAPHY REACHES QUALITY REQUIREMENTS

After successfully implementing fine-tuning in production, Nanologica’s product now meets the company’s own requirements for quality in all evaluated parameters. The company is therefore continuing to formally approve products to be able delivery to customers progressively. ”After making further fine-tunings in one of the production steps, we now have a product that we are satisfied with and that we can proudly deliver to customers. Finally! This means that we now can move on with the

Read more »

Nanologica’s Annual Report 2022 Published

Nanologica AB’s annual report for 2022 is now published on the company’s website. The annual report in Swedish, and an English translation, is available on www.nanologica.com as a pdf. The annual report in Swedish is also available in the European Single Electronic Format (ESEF). Swedish: https://nanologica.com/category/finansiella-rapporter/ English translation: https://nanologica.com/category/financial-reports/   For further information, please contact: Johanna Johansson, Director IR, Communications and Marketing Ph: +46 72 211 21 90 or e-mail: ir@nanologica.com This information is information that

Read more »